| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.73 | 0.007 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |